Log In
BCIQ
Print this Print this
 

VAL-017 (formerly 4s3-005)

  Manage Alerts
Collapse Summary General Information
Company Valerion Therapeutics LLC
DescriptionFusion protein of the delivery antibody 3E10 linked to a glycogen debrancher enzyme (GDE)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentDiscovery
Standard IndicationGlycosphingolipid storage disorders
Indication DetailsTreat Cori disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today